Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

Kazem Rahimi(University of Oxford), Takayoshi Ohkubo(Teikyo University), Barry R. Davis(National Institutes of Health), Yoshihiko Kanno(Tokyo Medical University), John B. Kostis(Johnson University), Lars Lindholm(Umeå University), Emma Copland(Oxford Health NHS Foundation Trust), Ana‐Catarina Pinho‐Gomes(The George Institute for Global Health), Hiroshi Ogawa(Kumamoto University), Stephen MacMahon, Steven Nissen, Jan Lanke, Stephan Lueders, Nigel Beckett, Mark Woodward(UNSW Sydney), Folkert W. Asselbergs(Health Data Research UK), Edmund J. Lewis, Dexter Canoy, Rury R. Holman(University of Oxford), Rema Ramakrishnan, Ale Algra(University Medical Center Utrecht), Julia B. Lewis, Masao Ishii(Japan Meteorological Agency), Amanda Adler(Oxford Centre for Diabetes, Endocrinology and Metabolism), Jamie P. Dwyer(University of Utah), Zeinab Bidel, Frank P. Brouwers, Toshio Ogihara(Osaka University), Milad Nazarzadeh, Giuseppe Mancia(University of Milano-Bicocca), Sverre E. Kjeldsen(Oslo University Hospital), Tsuguya Fukui(St. Luke's International Hospital), Maria H. Mehlum, Robert P. Byington, Masunori Matsuzaki(Ube (Japan)), Morris J. Brown(St Bartholomew's Hospital), Jeffrey A. Cutler(Unknown), Eivind Berge, Henry R. Black(Rush University Medical Center), Larry Agodoa, Kizuku Kuramoto, Robert Fagard, Ray Estacio, Richard B Devereaux, Michel Lièvre, Stevo Julius, Ajay Gupta, Christopher J. Bulpitt, William C. Cushman(University of Tennessee Health Science Center), Yutaka Imai(Court of Appeal)
The Lancet
April 29, 2021
Cited by 997


Related Papers